Pulsenmore Ltd.
PLSM Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$1.73
KIRA · Stoqly’s AI analyst, in plain words
- Pulsenmore Ltd. had $11.6M of revenue in fiscal 2025, up 344.1% on the year before.
- Pulsenmore Ltd. lost $4.6M in fiscal 2025. From fiscal 2023 to 2025, diluted EPS grew −46.3% a year.
- Free cash flow was −$9.6M in fiscal 2025, −82.5% of revenue.
Market cap
$11.1M
P/E
2.4x
Revenue
$11.6M
Net income
−$4.6M
Free cash flow
−$9.6M
Operating margin
—
Pulsenmore Ltd. in 30 seconds · fiscal 2025
Are sales growing?
+344.1%
Yes. Sales grew 344.1% last year.
Does it make a profit?
−39.6%
No. It lost money last year.
Does profit turn into cash?
−82.5%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
2.4x
One share costs 2.4 times its yearly profit per share.
What Pulsenmore Ltd. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Mar 30, 2026
- Legal name
- Pulsenmore Ltd.
- CIK
- 0002064764
Pulsenmore Ltd. · PLSM
Results and finances
The last 3 fiscal years. Amounts in USD.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Sales and profit | |||
| Revenue | $1.7M | $2.6M | $11.6M |
| Revenue growth | — | 55.6% | 344.1% |
| Gross margin | 35.6% | 37.0% | 84.2% |
| Net income | −$15.9M | −$9.9M | −$4.6M |
| Net margin | −946.5% | −380.3% | −39.6% |
| Diluted EPS | $2.47 | $1.56 | $0.71 |
| Cash | |||
| Cash from operations | −$13.5M | −$11.2M | −$9.5M |
| Capital expenditure | $1.1M | $0.1M | $0.0M |
| Free cash flow | −$14.5M | −$11.3M | −$9.6M |
| FCF margin | −866.1% | −434.4% | −82.5% |
| Share count change | — | 0.0% | 0.6% |
| Debt and strength | |||
| Cash and short-term investments | $6.6M | $11.3M | $6.8M |
| Shareholders' equity | $36.5M | $26.6M | $26.1M |
| Current ratio | — | 9.3x | 7.9x |
| Returns and quality | |||
| Return on equity | −43.5% | −31.5% | −17.5% |
| Return on tangible equity | −43.5% | −37.4% | −17.6% |
| Piotroski F-score | — | — | 3 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Pulsenmore Ltd. · PLSM
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.73 a share, the company is worth $11.1M: 2.4 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0002064764). Data updated October 24, 2026. Filed in ILS under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.